REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Inmunohematologico Especializado S.A.S (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio Inmunohematologico Especializado S.A.S Profile Updated: August 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Inmunohematologico Especializado S.A.S is an enterprise in Colombia, with the main office in Manizales. It operates in the Diagnostic Imaging Centers sector. Laboratorio Inmunohematologico Especializado S.A.S was incorporated on September 08, 2003. 3 (2024) employees currently work for Laboratorio Inmunohematologico Especializado S.A.S. In its most recent financial highlights, the company reported a net sales revenue drop of 0.98% in 2023. Its’ total assets recorded a negative growth of 27.6%. The net profit margin of Laboratorio Inmunohematologico Especializado S.A.S decreased by 1.29% in 2023.

Headquarters
Cra 23 57-09 Cons 09
Manizales; Caldas;

Contact Details: Purchase the Laboratorio Inmunohematologico Especializado S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Inmunohematologico Especializado S.A.S report to view the information.
Outstanding Shares:
Purchase the Laboratorio Inmunohematologico Especializado S.A.S report to view the information.
Incorporation Date:
September 08, 2003
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Inmunohematologico Especializado S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-0.98%
Total operating revenue
-0.98%
Operating profit (EBIT)
-16.69%
EBITDA
-15.5%
Net Profit (Loss) for the Period
-12.67%
Total assets
-27.6%
Total equity
-20.95%
Operating Profit Margin (ROS)
-4.07%
Net Profit Margin
-1.29%
Return on Equity (ROE)
1.92%
Quick Ratio
2.9%
Cash Ratio
2.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?